References
- Walther BS, Gibbons G, Chan EF, . LC (involving chronic lymphocytic leukemia) within excisional specimens: a series of 6 cases. Am J Dermatopathol 2009;31:162–165.
- Ali L, Cheney R, Merzianu M. Subclinical chronic lymphocytic leukemia with atypical cutaneous presentation. J Cutan Pathol 2011;38:236–240.
- Agnew KL, Ruchlemer R, Catovsky D, . Cutaneous findings in chronic lymphocytic leukaemia. Br J Dermatol 2004;150:1129–1135.
- Jasim ZF, Cooke N, Somerville JE, . Chronic lymphocytic leukaemia skin infiltrates affecting prominent parts of the face and the scalp. Br J Dermatol 2006;154:981–982.
- Plaza JA, Comfere NI, Gibson LE, . Unusual cutaneous manifestations of B-cell chronic lymphocytic leukemia. J Am Acad Dermatol 2009;60:772–780.
- Marinas EA, Vidaurrazaga N, Burgos-Bretones JJ, . Cutaneous reactive angiomatosis associated with chronic lymphoid leukemia. Am J Dermatopathol 2008;30:604–607.
- Mintz EM, Marneros A, Grossman ME. Leukemic leonine facies: a manifestation of chronic lymphocytic leukemia. Leuk Lymphoma 2008;49:1217–1219.
- Schneiderman PI, Grossman ME. A clinician’s guide to dermatologic differential diagnosis. Abingdon, UK: Informa; 2006.
- Cho-Vega JH, Medeiros LJ, Prieto VG, . LC. Am J Clin Pathol 2008;129:130–142.
- Cerroni L, Zenahlik P, Hofler G, . Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia: a clinicopathologic and prognostic study of 42 patients. Am J Surg Pathol 1996;20:1000–1010.
- Robak E, Robak T. Skin lesions in chronic lymphocytic leukemia. Leuk Lymphoma 2007;48:855–865.
- Smoller BR, Warnke RA. Cutaneous infiltrate of chronic lymphocytic leukemia and relationship to primary cutaneous epithelial neoplasms. J Cutan Pathol 1998;25:160–164.
- Hallek M, Fischer K, Fingerle-Rowson G, . Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet 2010;376:1164–1174.
- Batycka-Baran A, Baran W, Dzietczenia J, . Effective treatment of LC with combination of rituximab, cladribine, and cyclophosphamide in patient with B-cell chronic lymphocytic leukemia. Ann Hematol 2011;90:979–980.
- Castro JE, James DF, Sandoval-Sus JD, . Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia. Leukemia 2009;23:1779–1789.